Showing results (621-630 of 1,286) with videos related to

Sort By:
Pageof 129
European Journal of Preventive Cardiology|December 1, 2016
Relationship between outdoor temperature and cardiovascular disease risk factors in older peopleClaudio Sartini, Sarah Je Barry, Peter H Whincup, et al.
European Heart Journal|August 26, 2022
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programmeFaiez Zannad, João Pedro Ferreira, Javed Butler, et al.
Atherosclerosis|January 14, 2024
Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK BiobankPaul Welsh, Anas Al Zabiby, Hannah Byrne, et al.
Diabetes, Obesity & Metabolism|August 31, 2021
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trialMuthiah Vaduganathan, Silvio E Inzucchi, Naveed Sattar, et al.
The Journal of Physiology|April 21, 2007
Prospective targeting and control of end-tidal CO2 and O2 concentrationsMarat Slessarev, Jay Han, Alexandra Mardimae, et al.
Journal of Clinical Monitoring and Computing|June 17, 2005
Calculation of O2 consumption during low-flow anesthesia from tidal gas concentrations, flowmeter, and minute ventilationTakafumi Azami, David Preiss, Ron Somogyi, et al.
Circulation|July 16, 2003
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention StudyNaveed Sattar, Allan Gaw, Olga Scherbakova, et al.
Diabetologia|May 22, 2017
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetesSara J Jenks, Bryan R Conway, Stela McLachlan, et al.
American Heart Journal|May 28, 2018
Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trialThomas J Ford, David Corcoran, Keith G Oldroyd, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 21, 2018
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 StudiesHenry N Ginsberg, Michel Farnier, Jennifer G Robinson, et al.
Pageof 129